Literature DB >> 21812535

Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.

Tobias Herold, Till Seiler, Rupert Egensperger, Christoph Trumm, Manuela Bergmann, Daniel Franke, Friederike F H Mumm, Nicole Schinwald, Christian Buske, Martin Dreyling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21812535     DOI： 10.3109/10428194.2011.608446

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).

Authors:  Clive S Zent; Xin Victoria Wang; Rhett P Ketterling; Curtis A Hanson; Edward N Libby; Jacqueline C Barrientos; Timothy G Call; Julie E Chang; Jane J Liu; Alejandro R Calvo; Hillard M Lazarus; Jacob M Rowe; Selina M Luger; Mark R Litzow; Martin S Tallman
Journal:  Am J Hematol       Date:  2016-02-09       Impact factor: 10.047

2.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 3.  A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia.

Authors:  Melissa Gabriel; Bianca A W Hoeben; Hilde Hylland Uhlving; Olga Zajac-Spychala; Anita Lawitschka; Dorine Bresters; Marianne Ifversen
Journal:  Front Pediatr       Date:  2021-12-23       Impact factor: 3.418

4.  A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris.

Authors:  Sudip Das; Komal Agarwal; Sonal Singh; Deepika Halder; Sujata Sinha; Abhishek De
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.